Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey I Weitz

Showing results (1-10 of 445) with videos related to

Pageof 45
Sort By:
Thrombosis Research|January 4, 2011
Factor Xa and thrombin as targets for new oral anticoagulantsJeffrey I Weitz
Circulation|September 16, 2024
Arterial Thrombosis: Present and FutureJeffrey I Weitz
Circulation|September 2, 2004
Management of venous thromboembolism: present and futureJeffrey I Weitz
Thrombosis and Haemostasis|September 6, 2006
Emerging themes in the treatment of venous thromboembolismJeffrey I Weitz
Thrombosis Research|March 24, 2009
Unanswered questions in venous thromboembolismJeffrey I Weitz
Thrombosis and Haemostasis|January 12, 2010
New oral anticoagulants in developmentJeffrey I Weitz
The Journal of Clinical Investigation|April 3, 2003
Heparan sulfate: antithrombotic or not?Jeffrey I Weitz
Seminars in Respiratory and Critical Care Medicine|February 17, 2017
Reversal of Direct Oral Anticoagulants: Current Status and Future DirectionsJeffrey I Weitz
Thrombosis and Haemostasis|September 6, 2006
Emerging anticoagulants for the treatment of venous thromboembolismJeffrey I Weitz
Thrombosis Research|June 24, 2003
A novel approach to thrombin inhibitionJeffrey I Weitz
Pageof 45

Showing results (1-10 of 445) with videos related to

Sort By:
Pageof 45
Thrombosis Research|January 4, 2011
Factor Xa and thrombin as targets for new oral anticoagulantsJeffrey I Weitz
Circulation|September 16, 2024
Arterial Thrombosis: Present and FutureJeffrey I Weitz
Circulation|September 2, 2004
Management of venous thromboembolism: present and futureJeffrey I Weitz
Thrombosis and Haemostasis|September 6, 2006
Emerging themes in the treatment of venous thromboembolismJeffrey I Weitz
Thrombosis Research|March 24, 2009
Unanswered questions in venous thromboembolismJeffrey I Weitz
Thrombosis and Haemostasis|January 12, 2010
New oral anticoagulants in developmentJeffrey I Weitz
The Journal of Clinical Investigation|April 3, 2003
Heparan sulfate: antithrombotic or not?Jeffrey I Weitz
Seminars in Respiratory and Critical Care Medicine|February 17, 2017
Reversal of Direct Oral Anticoagulants: Current Status and Future DirectionsJeffrey I Weitz
Thrombosis and Haemostasis|September 6, 2006
Emerging anticoagulants for the treatment of venous thromboembolismJeffrey I Weitz
Thrombosis Research|June 24, 2003
A novel approach to thrombin inhibitionJeffrey I Weitz
Pageof 45